Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Long-Term Deferred Tax (2022 - 2025)

Historic Long-Term Deferred Tax for Immunocore Holdings (IMCR) over the last 4 years, with Q3 2025 value amounting to $14.3 million.

  • Immunocore Holdings' Long-Term Deferred Tax rose 1318.8% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year increase of 1318.8%. This contributed to the annual value of $14.8 million for FY2024, which is 3478.54% up from last year.
  • As of Q3 2025, Immunocore Holdings' Long-Term Deferred Tax stood at $14.3 million, which was up 1318.8% from $14.1 million recorded in Q2 2025.
  • In the past 5 years, Immunocore Holdings' Long-Term Deferred Tax ranged from a high of $14.8 million in Q4 2024 and a low of $5.1 million during Q4 2022
  • Its 4-year average for Long-Term Deferred Tax is $11.9 million, with a median of $12.7 million in 2024.
  • As far as peak fluctuations go, Immunocore Holdings' Long-Term Deferred Tax surged by 11427.46% in 2023, and later surged by 1318.8% in 2025.
  • Over the past 4 years, Immunocore Holdings' Long-Term Deferred Tax (Quarter) stood at $5.1 million in 2022, then surged by 114.27% to $11.0 million in 2023, then soared by 34.79% to $14.8 million in 2024, then dropped by 3.09% to $14.3 million in 2025.
  • Its Long-Term Deferred Tax was $14.3 million in Q3 2025, compared to $14.1 million in Q2 2025 and $14.4 million in Q1 2025.